Disclosed herein are novel genes and methods for the screening of therapeutics useful for treating impaired glucose tolerance conditions, as well as diagnostics and therapeutic compositions for identifying or treating such conditions.

 
Web www.patentalert.com

< Spinal fusion using an HMG-CoA reductase inhibitor

< GPE analogs and peptidominetics

> Borellia burgdorferi epitope peptides

> Allograft bone composition having a gelatin binder

~ 00262